Verhagen, N.E.; Koenderink, J.B.; Blijlevens, N.M.A.; Janssen, J.J.W.M.; Russel, F.G.M.
Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia. Pharmaceutics 2023, 15, 2535.
https://doi.org/10.3390/pharmaceutics15112535
AMA Style
Verhagen NE, Koenderink JB, Blijlevens NMA, Janssen JJWM, Russel FGM.
Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia. Pharmaceutics. 2023; 15(11):2535.
https://doi.org/10.3390/pharmaceutics15112535
Chicago/Turabian Style
Verhagen, Noor E., Jan B. Koenderink, Nicole M. A. Blijlevens, Jeroen J. W. M. Janssen, and Frans G. M. Russel.
2023. "Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia" Pharmaceutics 15, no. 11: 2535.
https://doi.org/10.3390/pharmaceutics15112535
APA Style
Verhagen, N. E., Koenderink, J. B., Blijlevens, N. M. A., Janssen, J. J. W. M., & Russel, F. G. M.
(2023). Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia. Pharmaceutics, 15(11), 2535.
https://doi.org/10.3390/pharmaceutics15112535